Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Science Translational Medicine|October 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSalo N Ooft, Fleur Weeber, Krijn K Dijkstra, et al.Cell|August 14, 2018
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor OrganoidsKrijn K Dijkstra, Chiara M Cattaneo, Fleur Weeber, et al.Nature|January 11, 2023
γδ T cells are effectors of immunotherapy in cancers with HLA class I defectsNatasja L de Vries, Joris van de Haar, Vivien Veninga, et al.Scientific Reports|May 16, 2024
Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanomaLindsay V M Leek, Jessica C L Notohardjo, Karlijn de Joode, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2024
Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery ProtocolBirgit S Geurts, Laurien J Zeverijn, Lindsay V M Leek, et al.Nature Medicine|January 8, 2024
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trialYara L Verschoor, Joris van de Haar, José G van den Berg, et al.Nature Genetics|July 4, 2025
The synthetic lethal interaction between CDS1 and CDS2 is a vulnerability in uveal melanoma and across multiple tumor typesPui Ying Chan, Diana Alexander, Ishan Mehta, et al.Cancer Cell|July 4, 2025
Subclonal immune evasion in non-small cell lung cancerKrijn K Dijkstra, Roberto Vendramin, Despoina Karagianni, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided TreatmentLouisa R Hoes, Jade M van Berge Henegouwen, Hanneke van der Wijngaart, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 18, 2024
The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery ProtocolLaurien J Zeverijn, Birgit S Geurts, Thomas W Battaglia, et al.Pageof 3